Traditional Chinese Medicine: Role in Reducing β-Amyloid, Apoptosis, Autophagy, Neuroinflammation, Oxidative Stress, and Mitochondrial Dysfunction of Alzheimer's Disease
89
TL;DR: Traditional Chinese Medicine monomers and extracts from TCM have potential therapeutic effect for AD treatment and among these herbal medicines, the Lamiaceae family accounts for the highest proportion.
read more
Abstract: Alzheimer's disease (AD) is a progressive age-related neurodegenerative disease characterized by memory loss and cognitive impairment. The major characteristics of AD are amyloid β plaques, apoptosis, autophagy dysfunction, neuroinflammation, oxidative stress, and mitochondrial dysfunction. These are mostly used as the significant indicators for selecting the effects of potential drugs. It is imperative to explain AD pathogenesis and realize productive treatments. Although the currently used chemical drugs for clinical applications of AD are effective in managing the symptoms, they are inadequate to achieve anticipated preventive or therapeutic outcomes. There are new strategies for treating AD. Traditional Chinese Medicine (TCM) has accumulated thousands of years of experience in treating dementia. Nowadays, numerous modern pharmacological studies have verified the efficacy of many bioactive ingredients isolated from TCM for AD treatment. In this review, representative TCM for the treatment of AD are discussed, and among these herbal medicines, the Lamiaceae family accounts for the highest proportion. It is concluded that monomers and extracts from TCM have potential therapeutic effect for AD treatment.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Dietary polyphenols: regulate the advanced glycation end products-RAGE axis and the microbiota-gut-brain axis to prevent neurodegenerative diseases.
TL;DR: Polyphenols with multiple hydroxyl groups showed a powerful ability to scavenge ROS and capture α-dicarbonyl species, which led to the formation of mono- and di- adducts, thereby inhibiting AGEs formation.
96
Natural Drugs as a Treatment Strategy for Cardiovascular Disease through the Regulation of Oxidative Stress.
TL;DR: Advances in the use of active CHM components that modulate oxidative stress are reviewed, suggesting potential drugs for the treatment of various CVDs.
The Emerging Role of Central and Peripheral Immune Systems in Neurodegenerative Diseases
TL;DR: This review highlights the emerging role of the peripheral and central immune systems in neurodegenerative diseases, as well as their interactions, and suggests that a better understanding of the emerging roles of the immune systems may improve therapeutic strategies for neurodegenersative diseases.
67
Neuroprotective Effect of Artichoke-Based Nanoformulation in Sporadic Alzheimer’s Disease Mouse Model: Focus on Antioxidant, Anti-Inflammatory, and Amyloidogenic Pathways
Heba A. S. El-Nashar,Haidy Abbas,Mariam Zewail,Mohamed H. Noureldin,Mai M. Ali,Marium M. Shamaa,Mohamed H. Khattab,Nehal Ibrahim +7 more
TL;DR: Significant neuroprotective efficacy in dentate Gyrus sub-regions was achieved in mice treated with free artichoke extract and to a significantly higher extent with artichokes-loaded SLNs, indicating possibly better physicochemical and biopharmaceutical parameters than free artICHoke extract.
Therapeutic non-invasive brain treatments in Alzheimer’s disease: recent advances and challenges
TL;DR: In this article , the advances of the most widely studied non-invasive therapies, including photobiomodulation (PBM), transcranial magnetic stimulation (TMS), and exercise therapy, are reviewed.
References
The amyloid hypothesis of Alzheimer's disease at 25 years
Dennis J. Selkoe,John Hardy +1 more
TL;DR: In a recent study, this article showed that low cerebrospinal fluid (CSF) Aβ42 and amyloid-PET positivity precede other AD manifestations by many years.
5K
Neuropathological Alterations in Alzheimer Disease
TL;DR: Postmortem studies have enabled the staging of the progression of both amyloid and tangle pathologies, and the development of diagnostic criteria that are now used worldwide, and these cross-sectional neuropathological data have been largely validated by longitudinal in vivo studies using modern imaging biomarkers such as amyloids PET and volumetric MRI.
The amyloid hypothesis of Alzheimer's disease at 25years
DJ Selkoe,John Hardy +1 more
- 01 Jun 2016
TL;DR: Although many factors contribute to AD pathogenesis, Aβ dyshomeostasis has emerged as the most extensively validated and compelling therapeutic target.
2.9K
Skepinone-L, a Novel Potent and Highly Selective Inhibitor of p38 MAP Kinase, Effectively Impairs Platelet Activation and Thrombus Formation
Oliver Borst,Britta Walker,Patrick Münzer,Antonella Russo,Evi Schmid,Caterina Faggio,Boris Bigalke,Stefan Laufer,Meinrad Gawaz,Florian Lang +9 more
TL;DR: Skepinone-L did not impair platelet Ca2+ signaling but prevented agonist-induced thromboxane A2 synthesis through abrogation of p38 MAPK-dependent phosphorylation of platelet cytosolic phospholipase A2 (cPLA2).
ABAD Directly Links Aß to Mitochondrial Toxicity in Alzheimer's Disease
Joyce W. Lustbader,Maurizio Cirilli,Chang Lin,Hongwei Xu,Hongwei Xu,Kazuhiro Takuma,Ning Wang,Casper Caspersen,Xi Chen,Susan Pollak,Michael O. Chaney,Fabrizio Trinchese,Shumin Liu,Frank J. Gunn-Moore,Lih-Fen Lue,Douglas G. Walker,Periannan Kuppusamy,Zay L. Zewier,Ottavio Arancio,David M. Stern,Shirley ShiDu Yan,Hao Wu +21 more
TL;DR: It is demonstrated that Aβ-binding alcohol dehydrogenase (ABAD) is a direct molecular link from Aβ to mitochondrial toxicity and the ABAD-Aβ interaction may be a therapeutic target in Alzheimer's disease.